Indian COVID-19 vaccine proves effective in early trials — bringing relief to the millions who have already gotten it

Indian drug company Bharat Biotech said late Wednesday that initial results from clinical trials showed that its Covaxin vaccine had an efficacy rate of 81 per cent.